Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition

BACKGROUND: Compared to conventional chemotherapy, Immune checkpoint inhibitors (ICI) are known to have a distinct toxicity profile commonly identified as immune-related adverse events (irAEs). These irAEs that are believed to be related to immune dysregulations triggered by ICI can be serious and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Naqash, Abdul Rafeh, Appah, Ebenezer, Yang, Li V., Muzaffar, Mahvish, Marie, Mona A., Mccallen, Justin D., Macherla, Shravanti, Liles, Darla, Walker, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612131/
https://www.ncbi.nlm.nih.gov/pubmed/31277704
http://dx.doi.org/10.1186/s40425-019-0648-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612131/
https://www.ncbi.nlm.nih.gov/pubmed/31277704
http://dx.doi.org/10.1186/s40425-019-0648-3

Ejemplares similares